Teva Stock To Go Ex-dividend Tomorrow (TEVA)

NEW YORK (TheStreet) -- The ex-dividend date for Teva Pharmaceutical Industries (Nasdaq:TEVA) is tomorrow, February 23, 2012. Owners of shares as of market close today will be eligible for a dividend of 20 cents per share. At a price of $44.61 as of 9:30 a.m. ET, the dividend yield is 1.7%.

The average volume for Teva has been 5.4 million shares per day over the past 30 days. Teva has a market cap of $43.16 billion and is part of the health care sector and drugs industry. Shares are up 12.1% year to date as of the close of trading on Tuesday.

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs; and proprietary branded pharmaceuticals in various therapeutic categories and active pharmaceutical ingredients worldwide. The company has a P/E ratio of 9.5, below the average drugs industry P/E ratio of 13.7 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Teva as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Teva Ratings Report.

See our dividend calendar or top-yielding stocks list.

For more information on Teva Pharmaceutical Industries Ltd click any of the following:

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
Login Try it Free
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Login Try it Free
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Login Try it Free
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
Login Try it Free
Dow Jones S&P 500 NASDAQ 10-Year Note
12,248.89 1,288.39 2,785.13 14.74
Oil *
99.38
DOWN
144.56
DOWN
21.94
DOWN
42.21
DOWN
1.07
10 Yr
1.47%
SPDR Gold
155.20
-1.17%
-1.67%
-1.49%
-6.77%
Data delayed 20 minutes

Latest Trade Alerts

See all

Articles From